Magnetic resonance imaging, referred by general practitioners for traumatic knee injuries, adds to healthcare costs without improvement in outcomes.
Magnetic resonance imaging for traumatic knee injuries, referred by general practitioners, leads to higher healthcare costs without improvement in outcomes, according to a study published in the journal Radiology.
Researchers from the Netherlands performed a cost-utility analysis parallel to a prospective randomized controlled trial of 356 patients who presented with traumatic knee symptoms. The group, mean age 33 years (from 18 to 45), included 222 men.
A total of 177 patients were randomly assigned to usual care, which did not include MR imaging, but patients were referred to an orthopedic surgeon when conservative treatment was unsatisfactory. The remaining 179 patients were referred for MR imaging within two weeks after injury. Main outcome measures were quality-adjusted life years (QALYs) and costs from a healthcare and societal perspective.
The results showed mean QALYs were 0.888 in the MR imaging group and 0.899 in the usual care group. Healthcare costs per patient were higher in the MR imaging group (€1,109) than in the usual care group (€837), mainly due to higher costs for MR imaging, with no reduction in the number of referrals to an orthopedic surgeon in the MR imaging group.
The researchers concluded that referral for MR imaging referral by general practitioners was not cost-effective in patients with traumatic knee symptoms and that MR imaging led to more healthcare costs, without an improvement in health outcomes.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
Adjunctive Brain Volume Quantification Tool for MRI Gets FDA Clearance
November 14th 2023Providing automated brain volume calculations based on MRI images, NeuroShield’s artificial intelligence (AI)-powered technology may help facilitate treatment for neurodegenerative conditions ranging from Alzheimer’s disease to epilepsy.